NCT00535795已完成3 期
A Phase III Study to Assess Conventional RT w/ Conventional Plus Accelerated Boost RT in the Treatment of Nasopharyngeal CA
适应症
干预措施
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 200
- 试验地点
- 2
- 主要终点
- safety and efficacy
研究概览
简要总结
Phase III: Assess conventional RT w/ conventional Plus accelerated boost RT in the treatment of nasopharyngeal CA
详细描述
It's a phase III study to assess conventional Rad Therapy with conventional Plus accelerated boost Rad Therapy in the treatment of nasopharyngeal carcinoma.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with nasopharyngeal Carcinoma
排除标准
- •Patients with carcinoma other than histo-pathologically confirmed nasopharyngeal CA
研究组 & 干预措施
1
Active Comparator
Conventional Radiation Therapy (XRT), one fraction per day, from Sunday to Thursday every week.
干预措施: Radiation Therapy (Radiation)
2
Experimental
Conventional Plus accelerated boost Radiation Therapy (XRT), from Sunday to Thursday every week.
干预措施: Radiation Therapy (Radiation)
结局指标
主要结局
safety and efficacy
时间窗: 5 years
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
进行中（未招募）
3 期
A Trial Evaluating the Addition of Nivolumab to Cisplatin-RT for Treatment of Cancers of the Head and NeckSquamous Cell Carcinoma of Head and NeckNCT03576417Groupe Oncologie Radiotherapie Tete et Cou680
Unknown
1 期
Combining SBRT and Immunotherapy in Early Stage NSCLC Patients Planned for SurgeryNSCLC, Stage INCT03446911Amsterdam UMC, location VUmc20
Unknown
3 期
Study of the Initial Combination of Bosentan With Iloprost in the Treatment of Pulmonary Hypertension PatientsPulmonary Arterial HypertensionNCT01712997Air Force Military Medical University, China90
已完成
不适用
Treatment With Rhinospray Plus in Patients With Acute Rhinitis in the Everyday Curative Routine in HungaryRhinitisNCT01971086Boehringer Ingelheim300
已完成
3 期
Confirmatory Phase III study of Nasodine Nasal Spray (povidone-iodine 0.5%) as a symptomatic treatment for early stage common cold in the natural setting.Infection - Other infectious diseasesRespiratory - Other respiratory disorders / diseasesCommon ColdACTRN12621000604808Firebrick Pharma Limited502